Zheng Zhou
0000-0001-7302-7384
Publication & Citation Trends
Publications
0 total
Inactivating LATS2 Variation Drives Tumor Progression and Resistance to Anti-PD-1 Therapy in Intrahepatic Cholangiocarcinoma.
Cited by 0
Semantic Scholar
The intratumoral balance of IgG4+ plasma cells and CD8+ T cells is associated with prognosis of intrahepatic cholangiocarcinoma after curative resection.
Cited by 1
Semantic Scholar
Erratum: A positive feedback loop between cancer stem-like cells and tumor-associated neutrophils controls hepatocellular carcinoma progression.
Cited by 0
Semantic Scholar
Corrigendum to "CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling" [Cancer Lett. 358 2015 Pages 124-135].
Cited by 0
Semantic Scholar
Integrated molecular characterization of sarcomatoid hepatocellular carcinoma
Cited by 4
Semantic Scholar
Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma OA
Cited by 8
Semantic Scholar
[Corrigendum] Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway OA
Cited by 0
Semantic Scholar
Correction: MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET–SOCS1–MMP9 signaling axis
Cited by 1
Semantic Scholar
Research Topics
COVID-19 Clinical Research Studies
(8)
SARS-CoV-2 and COVID-19 Research
(6)
Long-Term Effects of COVID-19
(6)
Reproductive tract infections research
(4)
Bacterial Infections and Vaccines
(4)
Affiliations
Fujian University of Traditional Chinese Medicine
University of Science and Technology of China
Shandong University
University of Illinois Urbana-Champaign
Chongqing University